Quantcast

Latest Monoclonal antibodies Stories

2014-04-30 10:21:24

May provide therapeutic target for treating inflammatory bowel disease and preventing colitis-associated colorectal cancer, according to new research published in the American Journal of Pathology The adhesion molecule CD146 plays a vital role in inflammation and offers a promising therapeutic target for treating inflammatory bowel disease (IBD) as well as preventing colitis-associated colorectal cancer, say scientists. Targeting CD146 with anti-CD146 antibody AA98, especially in...

2014-04-30 08:33:09

Proprietary "Smart Antibodies" Allow for Selective Activation in Cancerous Tissues SAN DIEGO, April 30, 2014 /PRNewswire/ -- BioAtla, a global biotechnology company focused on the development of differentiated biological therapeutics, today announced that the United States Patent and Trademark Office (USPTO) has issued to BioAtla U.S. Patent No. 8,709,755, its first patent directed to methods of generating conditionally active antibodies. Conditionally active antibodies are...

2014-04-29 08:35:33

MONROVIA, Calif., April 29, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will present at the Deutsche Bank 39th Annual Health Care Conference on Wednesday, May 7, 2014 at 4:50 p.m. EDT in Boston, MA. A live audio webcast of the...

2014-04-29 08:35:02

MUMBAI, April 29, 2014 /PRNewswire/ -- SOURCE Glenmark Pharmaceuticals

2014-04-28 12:27:09

Rheumatologists Cite Improved Health-Related Quality of Life, Improved Effect in Disease Activity among Unmet Needs, According to Findings from Decision Resources Group BURLINGTON, Mass., April 28, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. and EU5 rheumatologists agree that new therapies for the treatment of moderate to severe systemic lupus erythematosus (SLE) that offer improved effect on disease activity and renal organ domain scores over current therapies...

2014-04-23 16:23:51

DUBLIN, April 23, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cqslzn/chromatography) has announced the addition of the "Chromatography Resin Market by Application, Techniques & Type - Trends & Forecast to 2018" [http://www.researchandmarkets.com/research/cqslzn/chromatography ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Ever increasing application in monoclonal...

2014-04-23 08:31:22

The Department of Defense's WRAIR will study Lpath's anti-LPA antibody in the blast injury model of TBI SAN DIEGO, April 23, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, and scientists from the Center for Military Psychiatry and Neuroscience, Walter Reed Army Institute of Research (WRAIR), have initiated a study that is the focus of a collaborative research agreement. The collaboration involves the use of...

2014-04-21 12:27:26

Mucosal Healing and Maintenance of Remission Have High Influence in Gastroenterologists' Prescribing Decision for UC, According to Findings from Decision Resources Group BURLINGTON, Mass., April 21, 2014 /PRNewswire/ -- Decision Resources Group finds that, according to surveyed U.S. and EU5 gastroenterologists, effect on mucosal healing and improvement in the maintenance of remission are two of the attributes that most strongly influence their prescribing decisions in moderate to severe...

2014-04-16 09:48:04

Over 20 years after the fatal fialuridine trial, a study published this week in PLOS Medicine demonstrates that mice with humanized livers recapitulate the drug's toxicity. The work suggests that this mouse model should be added to the repertoire of tools used in preclinical screening of drugs for liver toxicity before they are given to human participants in clinical trials. A retrospective analysis by the US National Academy of Sciences of all preclinical fialuridine toxicity tests, which...

2014-04-16 08:32:44

U.S. Institutional Investors Lead Oversubscribed Round To Advance Monoclonal Antibody Clinical Programs For Companion Animal Health MELBOURNE, Australia, April 16, 2014 /PRNewswire/ -- Nexvet Biopharma, a leading veterinary biologic drug developer, today announced the closing of its US$31.5 million Series B round of financing. Top-tier U.S.-based institutional investors Farallon Capital Management, LLC, Adage Capital Partners, L.P, Foresite Capital, and Tavistock Life Sciences...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related